Showing results (2541-2550 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|December 14, 2018
Modulator of the PI3K/Akt oncogenic pathway affects mTOR complex 2 in human adenocarcinoma cellsBlair P Curless, Nne E Uko, Diane F Matesic
Investigational New Drugs|March 25, 2018
Post-progression survival following second-line chemotherapy in patients with advanced pancreatic cancer previously treated with gemcitabine: a meta-analysisAkiyoshi Kasuga, Yasuo Hamamoto, Ayano Takeuchi, et al.
Investigational New Drugs|December 1, 1988
Chemotherapy of the squamous cell lung cancer LC-12 with 5-fluorouracil, cisplatin, carboplatin or iproplatin combinationsE Tapazoglou, L Polin, T H Corbett, et al.
Investigational New Drugs|January 21, 2019
In vitro and in vivo cytotoxic activity and human serum albumin interaction for a methoxy-styryl-thiosemicarbazoneOtávio Augusto Chaves, Isabela S de Castro, Carla Marins Goulart, et al.
Investigational New Drugs|February 12, 2019
An orally antitumor chalcone hybrid inhibited HepG2 cells growth and migration as the tubulin binding agentWang Yan, Chen Xiangyu, Li Ya, et al.
Investigational New Drugs|October 28, 2017
Radiomics to predict immunotherapy-induced pneumonitis: proof of conceptRivka R Colen, Takeo Fujii, Mehmet Asim Bilen, et al.
Investigational New Drugs|October 30, 2017
Combined treatment with pemetrexed and vinflunine in patients with metastatic urothelial cell carcinoma after prior platinum-containing chemotherapy - results of an exploratory phase I studyH Pappot, H von der Maase, A Ullén, et al.
Investigational New Drugs|October 30, 2017
Ganoderic acid, lanostanoid triterpene: a key player in apoptosisBalraj Singh Gill, Navgeet, Richa Mehra, et al.
Investigational New Drugs|January 30, 2018
First-in-human phase I dose escalation study of MK-8033 in patients with advanced solid tumorsVicki L Keedy, Heinz-Josef Lenz, Leonard Saltz, et al.
Investigational New Drugs|January 1, 1985
Synergistic combination of menogarol and melphalan and other two drug combinationsB K Bhuyan, E G Adams, M Johnson, et al.
Pageof 372